Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeREGENTIS BIOMATERIALS

REGENTIS BIOMATERIALS

Regentis Expands SAGE Clinical Trial Study of GelrinC for Damaged Articular Cartilage

Regentis Biomaterials today announced it has expanded the SAGE clinical trial of GelrinC™ for the treatment of articular cartilage damage in the knee to 11 U.S. sites. GelrinC is an investigational device being evaluated as a treatment...

By using this website you agree to accept Medical Device News Magazine Privacy Policy